Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment

INTRODUCTION: Osteoporosis is one of the serious adverse effects associated with glucocorticoid therapy. Although bisphosphonates have been used for glucocorticoid-induced osteoporosis (GIO), some patients have shown an inadequate response. In such cases, denosumab or teriparatide are used. However,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bone Rep
Hlavní autoři: Hirooka, Yasuaki, Nozaki, Yuji, Inoue, Asuka, Li, Jinhai, Shiga, Toshihiko, Kishimoto, Kazuya, Sugiyama, Masafumi, Kinoshita, Koji, Funauchi, Masanori, Matsumura, Itaru
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352055/
https://ncbi.nlm.nih.gov/pubmed/32676524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2020.100293
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky